(VIANEWS) – First Citizens BancShares (FCNCA), Schrodinger (SDGR), Opera Limited (OPRA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. First Citizens BancShares (FCNCA)
87.8% sales growth and 70.84% return on equity
First Citizens BancShares, Inc. operates as the holding company for First-Citizens Bank & Trust Company that provides retail and commercial banking services to individuals, businesses, and professionals. The company's deposit products include checking, savings, money market, and time deposit accounts. Its loan product portfolio comprises commercial construction and mortgage; and commercial and industrial leases, as well as small business administration paycheck protection program loans. In addition, the company offers consumer loans, such as residential and revolving mortgage, construction and land development, consumer auto, and other consumer loans. Further, it provides wealth management services, including annuities, discount brokerage services, and third-party mutual funds, as well as investment management and advisory services. The company provides its products and services through its branch network. First Citizens BancShares, Inc. was founded in 1898 and is headquartered in Raleigh, North Carolina.
Earnings Per Share
As for profitability, First Citizens BancShares has a trailing twelve months EPS of $735.46.
PE Ratio
First Citizens BancShares has a trailing twelve months price to earnings ratio of 1.84. Meaning, the purchaser of the share is investing $1.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.84%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 123%, now sitting on 5.23B for the twelve trailing months.
2. Schrodinger (SDGR)
41.5% sales growth and 12.02% return on equity
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Earnings Per Share
As for profitability, Schrodinger has a trailing twelve months EPS of $0.81.
PE Ratio
Schrodinger has a trailing twelve months price to earnings ratio of 34.38. Meaning, the purchaser of the share is investing $34.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.02%.
Yearly Top and Bottom Value
Schrodinger’s stock is valued at $27.85 at 11:22 EST, way under its 52-week high of $59.24 and way higher than its 52-week low of $15.85.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 30.4% and positive 13.2% for the next.
Sales Growth
Schrodinger’s sales growth is 22% for the present quarter and 41.5% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.5%, now sitting on 193.79M for the twelve trailing months.
3. Opera Limited (OPRA)
11.1% sales growth and 6.9% return on equity
Opera Limited, together with its subsidiaries, provides mobile and PC web browsers. It operates in two segments, Browser and News, and Other. The company offers mobile browser products, such as Opera Mini, Opera for Android and iOS, Opera GX Mobile, and Opera Touch; PC browsers, including Opera for Computers and Opera GX; Apex Football; Opera VPN Pro; and Opera News, an AI-powered personalized news discovery and aggregation service. It also provides Opera Crypto Browser for PCs and mobile; browser-based cashback rewards; owns GameMaker Studio, a 2D gaming development platform; and GXC, a gaming portal. In addition, the company operates Opera Ads, an online advertising platform. It operates in Nigeria, Ireland, France, Germany, Spain, England, South Africa, Kenya, and internationally. The company was founded in 1995 and is headquartered in Oslo, Norway. Opera Limited is a subsidiary of Kunlun Tech Limited.
Earnings Per Share
As for profitability, Opera Limited has a trailing twelve months EPS of $0.6.
PE Ratio
Opera Limited has a trailing twelve months price to earnings ratio of 17.93. Meaning, the purchaser of the share is investing $17.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.9%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.9%, now sitting on 362.8M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Opera Limited’s EBITDA is 94.3.
Yearly Top and Bottom Value
Opera Limited’s stock is valued at $10.76 at 11:22 EST, way under its 52-week high of $28.58 and way above its 52-week low of $3.92.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 50% and a drop 40.7% for the next.
4. Banco Latinoamericano de Comercio Exterior, S.A. (BLX)
10.7% sales growth and 12.29% return on equity
Banco Latinoamericano de Comercio Exterior, S.A., a multinational bank, primarily engages in the financing of foreign trade in Latin America and the Caribbean. The company operates through two segments, Commercial and Treasury. It offers short and medium-term bilateral, structured and syndicated credits, and loan commitments; financial guarantee contracts, such as issued and confirmed letters of credit, and stand-by letters of credit; and guarantees covering commercial risk and other assets, as well as co-financing arrangements, underwriting of syndicated credit facilities, structured trade financing in the form of factoring and vendor financing, and financial leasing. The company also provides treasury solutions, which include term deposits and private placements. It primarily serves financial institutions, corporations, and sovereigns and state-owned entities. The company was formerly known as Banco Latinoamericano de Exportaciones, S.A. and changed its name to Banco Latinoamericano de Comercio Exterior, S.A. in June 2009. Banco Latinoamericano de Comercio Exterior, S.A. was founded in 1977 and is headquartered in Panama City, the Republic of Panama.
Earnings Per Share
As for profitability, Banco Latinoamericano de Comercio Exterior, S.A. has a trailing twelve months EPS of $3.63.
PE Ratio
Banco Latinoamericano de Comercio Exterior, S.A. has a trailing twelve months price to earnings ratio of 5.93. Meaning, the purchaser of the share is investing $5.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.29%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 46%, now sitting on 194.45M for the twelve trailing months.
5. Eaton Corporation (ETN)
9.3% sales growth and 15.79% return on equity
Eaton Corporation plc operates as a power management company worldwide. The company's Electrical Americas and Electrical Global segment provides electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality and connectivity products, wiring devices, circuit protection products, utility power distribution products, power reliability equipment, and services, as well as hazardous duty electrical equipment, emergency lighting, fire detection, explosion-proof instrumentation, and structural support systems. Its Aerospace segment offers pumps, motors, hydraulic power units, hoses and fittings, and electro-hydraulic pumps; valves, cylinders, electronic controls, electromechanical actuators, sensors, aircraft flap and slat systems, and nose wheel steering systems; hose, thermoplastic tubing products, fittings, adapters, couplings, and sealing and ducting products; air-to-air refueling systems, fuel pumps, fuel inerting products, sensors, and adapters and regulators; oxygen generation system, payload carriages, and thermal management products; and wiring connectors and cables, as well as hydraulic and bag filters, strainers and cartridges, and golf grips for manufacturers of commercial and military aircraft, and related after-market customers, as well as industrial applications. The company's Vehicle segment offers transmissions, clutches, hybrid power systems, superchargers, engine valves and valve actuation systems, locking and limited slip differentials, transmission controls, and fuel vapor components for the vehicle industry. Its eMobility segment provides voltage inverters, converters, fuses, onboard chargers, circuit protection units, vehicle controls, power distribution systems, fuel tank isolation valves, and commercial vehicle hybrid systems. Eaton Corporation plc was founded in 1911 and is based in Dublin, Ireland.
Earnings Per Share
As for profitability, Eaton Corporation has a trailing twelve months EPS of $6.76.
PE Ratio
Eaton Corporation has a trailing twelve months price to earnings ratio of 30.81. Meaning, the purchaser of the share is investing $30.81 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.79%.
Moving Average
Eaton Corporation’s worth is under its 50-day moving average of $218.97 and way above its 200-day moving average of $185.52.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 3, 2023, the estimated forward annual dividend rate is 3.44 and the estimated forward annual dividend yield is 1.64%.
6. Merit Medical Systems (MMSI)
7.5% sales growth and 7.87% return on equity
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Earnings Per Share
As for profitability, Merit Medical Systems has a trailing twelve months EPS of $1.58.
PE Ratio
Merit Medical Systems has a trailing twelve months price to earnings ratio of 43.68. Meaning, the purchaser of the share is investing $43.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.87%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Merit Medical Systems’s EBITDA is 3.62.
Volume
Today’s last reported volume for Merit Medical Systems is 428540 which is 21.53% above its average volume of 352612.
